- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06716073
Långtidsresultat av endoskopisk assisterad vs konventionell bröstbevarande kirurgi hos bröstcancerpatienter efter neoadjuvant terapi: en randomiserad, multicenter, öppen etikett, non-inferiority-prövning
With the title of "Long-Term Outcomes of endoscopic-assisted vs conventional breast-conserving surgery in breast cancer patients after neoadjuvant therapy: a randomized, multicenter, open label, non-inferiority trial", this study targets breast cancer patients after neoadjuvant therapy. A total of 804 eligible patients, after screening with inclusion and exclusion criteria, will be randomly assigned to Endoscopic-assisted breast conserving surgery(E-BCS) or conventional breast conserving surgery (C-BCS) group at a 1:1 ratio using stratified block randomization method, stratified by centers and molecular subtype. The co-primary endpoints are 5-year disease-free survival (5y-DFS) and Breast-Q score at 6 months after surgery. The secondary endpoints are cosmetic outcomes including surgeons' satisfaction with breast and patients' satisfaction with scar, survival outcomes including 5-year overall survival (5y-OS) and 5-year local-recurrence rate (5y-LRR), surgical outcomes including operative time, intraoperative blood loss, incision length and postoperative complications rate. This study aims to confirm the long-term safety and aesthetic outcome of endoscopic-assisted surgery in breast cancer patients after neoadjuvant treatment by comparing it with conventional open breast conserving surgery, and provide clinical evidence for the popularized application of endoscopic breast surgery.
Studieöversikt
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Shicheng Su
- Telefonnummer: +86-13631304227
- E-post: sushch@mail.sysu.edu.cn
Studera Kontakt Backup
- Namn: Yiwen Lu, Doctor
- Telefonnummer: +86-13268121885
- E-post: luyw8@mail.sysu.edu.cn
Studieorter
-
-
Guangdong
-
Guangzhou, Guangdong, Kina, 510120
- Rekrytering
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
-
Kontakt:
- Shicheng Su
- Telefonnummer: +86-13631304227
- E-post: sushch@mail.sysu.edu.cn
-
Shantou, Guangdong, Kina
- Har inte rekryterat ännu
- Sun Yat-sen Memorial Hospital of Sun Yat-sen University Shenzhen Shantou Central Hospital
-
Kontakt:
- Yandan Yao
- Telefonnummer: +86-13826292688
- E-post: yaoyand@mail.sysu.edu.cn
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Age ranging from 18 to 75 years
- Pathologically confirmed invasive breast cancer
- Receiving preoperative chemotherapy (Each molecular subtype corresponds to unanimous regimen)
- cT1-3N0-3M0
- Unilateral breast tumor
- Eastern Cooperative Oncology Group score 0-1
- Left Ventricular Ejection Fraction (LVEF) ≥50%
- Leukocytes ≥ 3.0×109/L, Absolute neutrophil count ≥ 1.5×109/L, Platelets ≥ 100×109/L, Hemoglobin ≥ 90g/L, Creatinine <1.5 × institutional ULN, Total bilirubin ≤ 2.0 × institutional ULN.
Exclusion Criteria:
- Diffusely disseminated malignant calcification foci
- Not applicable for BCS after neoadjuvant therapy
- Pregnancy or breastfeeding
- Additional malignancy
- Severe cardiopulmonary, liver or kidney dysfunction or other systemic diseases (such as uncontrolled chronic heart failure, critical hypertension or diabetes with poor blood glucose control).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Endoskopisk bröstbevarande kirurgi (E-BCS) grupp
|
comparison of 2 surgical procedures |
|
Inget ingripande: Konventionell bröstbevarande kirurgi (C-BCS) grupp
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
5-year disease free survival
Tidsram: From surgery to the end of follow-up at 5 years
|
The proportion of patients remaining after excluding patients with disease recurrence, metastasis or death from the time of surgery to 5-year follow-up |
From surgery to the end of follow-up at 5 years
|
|
Patients' satisfaction with breast
Tidsram: From surgery to the follow-up at 6 months
|
The score of Breast-Q scale "Satisfaction with breasts" table 6 months after surgery |
From surgery to the follow-up at 6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Surgeons' satisfaction with breast
Tidsram: From surgery to the follow-up at 6 months
|
Surgeons evaluate the cosmetic outcome of breast based on the photos before surgery and after surgery. Four ranks: Excellent (9-10 points), Good (7-8 points), Fair (5-6 points) and Poor (0-4 points) are categorized on a basis of average total score from Ueda scale |
From surgery to the follow-up at 6 months
|
|
Patients satisfaction with scar
Tidsram: From surgery to the follow-up at 6 months
|
Scar-Q scale including 3 tables about the surgical scar: appearance, symptom, psychosocial impact with total score of 100 will be used for evaluating patients satisfaction with scar |
From surgery to the follow-up at 6 months
|
|
5-year overall survival
Tidsram: From surgery to the end of follow-up at 5 years
|
The proportion of patients remaining after excluding patients who died from any cause at 5-year follow-up |
From surgery to the end of follow-up at 5 years
|
|
5-year local-regional recurrence rate
Tidsram: From surgery to the end of follow-up at 5 years
|
The proportion of patients with a lump found on breast, axilla, chest wall, skin or scars of surgery ipsilateral to the surgical side through physical examination or imaging, confirmed as the same pathological type as the primary tumor according to biopsy at 5-year follow up |
From surgery to the end of follow-up at 5 years
|
|
Postoperative complication rate
Tidsram: From surgery to the follow-up at 12 months
|
The proportion of patients with postoperative complications including hemorrhage, incision dehiscence, upper limb lymphedema, infection,seroma. |
From surgery to the follow-up at 12 months
|
|
Surgical duration
Tidsram: Intraoperative
|
The time from the beginning of surgery to the end of surgery |
Intraoperative
|
|
Intraoperative blood loss
Tidsram: Intraoperative
|
The blood loss during the operation |
Intraoperative
|
|
Incision length
Tidsram: Intraoperative
|
The length of surgical incision |
Intraoperative
|
Samarbetspartners och utredare
Utredare
- Studiestol: Shicheng Su, Doctor, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- SYSKY-2024-648-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .